Coming soon to AUSTEX Wellness!
DAXXIFY is the only FDA-approved Neuromodulator lasting 6-9 months!

On September 8, 2022, the FDA approved DAXXIFY, a long-lasting, peptide-powered injection for the treatment of fine lines and wrinkles.

Patients reported 6-month median duration, while some patients maintained treatment results at 9 months. Results were seen as early as one day after treatment, typically seen within two days.

AUSTEX Wellness is an Elite Partner with Revance Therapeutics, so we will be one of the first providers in Austin. DAXXIFY will likely release in November of this year.

DAXXIFY, powered by Peptide Exchange Technology, is the first true innovation in neuromodulator product formulation in over 30 years.

The manufacturer Revance Therapeutics is a biotechnology company focused on innovative aesthetic and therapeutic offerings. AUSTEX Wellness currently carries Revance’s entire portfolio of injectable fillers of RHA Redensity, RHA 2, RHA 3, and RHA 4.

DAXXIFY’s duration benefits were established in multiple phase 3 trials which included 2,700 patients and 4,200 treatments. The studies showed a single injection had a powerful effect on wrinkles!

We will be scheduling appointments with our Nurse Practitioner Lisa closer to the release date!

https://investors.revance.com/news-releases/news-release-details/revance-announces-fda-approval-daxxifytm-daxibotulinumtoxina